The milk-derived opioid peptide β-casomorphin-7 delays progression to the tonic–clonic phase and limits the increase in gamma band activity in acute pentylenetetrazole seizures in rats
Abstract Objective This study aimed to evaluate the effects of β-casomorphin-7 (BCM-7) on behavioural seizure responses and electrocorticographic (ECoG) activity in a pentylenetetrazole (PTZ)-induced acute seizure model, together with the possible contribution of the opioid receptor system to these effects. Methods Fifty-six male Wistar albino rats were randomly allocated to seven groups, designated SAL + SAL, VEH + SAL, BCM-7 + SAL, VEH + PTZ, BCM-7 + PTZ, NLX + BCM-7 + PTZ and NLX + VEH+PTZ, where SAL denotes saline, VEH the BCM-7 vehicle and NLX naloxone. BCM-7 (1 mg/kg), naloxone (2 mg/kg) and PTZ (70 mg/kg) were administered intraperitoneally. In the four PTZ-treated groups, the latencies to myoclonic jerk and to tonic–clonic seizure, the progression interval between these two events, seizure severity scored blind on coded video recordings according to the revised Racine scale, mortality and time of death were assessed, and survival was analysed using the Kaplan–Meier method and the log-rank test. ECoG recordings were examined by power spectral density analysis, and the absolute and relative powers of the frequency bands, total absolute power, median frequency and band ratios were calculated. Results In the planned comparison for myoclonic jerk latency, the latency was longer in the BCM-7 + PTZ group than in the VEH + PTZ group (p = .034). BCM-7 prolonged the tonic–clonic seizure latency approximately 1.5-fold and the myoclonic jerk–tonic–clonic seizure progression interval approximately 2.7-fold (both p < .001), and these effects were preserved in the presence of naloxone. PTZ markedly increased absolute power across all frequency bands in the groups in which naloxone was not administered alone. In the post-treatment measurements, gamma (p = .024) and HFA (p = .003) absolute powers were lower in the BCM-7 + PTZ group than in the VEH + PTZ group. The difference in total absolute power remained at the limit of significance (p = .053); however, this difference and those in the delta and HFA bands were also present before treatment, and the PTZ-induced increase in total power was comparable in the two groups. No significant difference was detected in theta, alpha or beta absolute power. Administration of naloxone alone limited the PTZ-induced increase in all absolute power measures. No overall difference between groups was found in Racine scores (p = .103), mortality rates (p = .182) or survival (log-rank p = .226). Nevertheless, death occurred later in the BCM-7 + PTZ group than in the VEH + PTZ group (median 17.0 vs. 10.0 min), whereas seizure severity (p = .020) and the risk of death (p = .043) were lower in the NLX + BCM-7 + PTZ group than in the BCM-7 + PTZ group. Conclusion In the acute PTZ model, BCM-7 displays a profile that delays progression to the tonic–clonic phase and limits the increase in gamma activity without markedly altering the PTZ-induced increase in total cortical power, rather than a classical anticonvulsant effect that fully prevents seizures. The preservation of the behavioural effects in the presence of naloxone, together with the independent ECoG effects of naloxone, suggests that the effects of BCM-7 may not be explained solely by naloxone-sensitive opioid mechanisms. The reduction in seizure severity and in the risk of death under co-administration with naloxone further suggests that a naloxone-sensitive component of BCM-7 may contribute to seizure severity and mortality.
Authors
- Hasan Fehmi Özel (ORCID: https://orcid.org/0000-0003-1676-0648)
- Şüheda Alpay (ORCID: https://orcid.org/0000-0003-3775-8491)
- Ertuğ EVREKLİ
Institutions
- Manisa Celal Bayar University (TR)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-17
- DOI
- https://doi.org/10.21203/rs.3.rs-11511306/v1
- Primary Topic
- Epilepsy research and treatment
- Type
- preprint